Cerus (CERS) Liabilities and Shareholders Equity (2010 - 2026)

Cerus (CERS) reported Liabilities and Shareholders Equity of $222.9 million for Q1 2026, up 7.8% on a YoY basis from $206.8 million in Q1 2025, and little changed sequentially from $221.9 million in Q4 2025.

Cerus (CERS) Liabilities and Shareholders Equity (2010 - 2026) Analysis & Trends

Cerus (CERS) has 17 years of Liabilities and Shareholders Equity data on file, last reported at $222.9 million in Q1 2026.

  • For the quarter ending Q1 2026, Liabilities and Shareholders Equity rose 7.8% year-over-year to $222.9 million; the trailing twelve-month figure through Mar 2026 stood at $873.0 million (up 11.54% YoY), and the FY2025 full-year result was $221.9 million, up 10.42% from the prior year.
  • Liabilities and Shareholders Equity steadied at $222.9 million in Q1 2026, from $221.9 million in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $222.9 million in Q1 2026 to a low of $185.5 million in Q2 2024.
  • A 5-year average of $207.6 million and a median of $209.3 million in 2023 frame the typical range for Liabilities and Shareholders Equity.
  • Across the five-year window, Liabilities and Shareholders Equity decreased 9.65% in 2024 and advanced 14.87% in 2025, its largest moves.
  • Tracing CERS's Liabilities and Shareholders Equity over 5 years: stood at $218.1 million in 2022, then fell by 9.33% to $197.7 million in 2023, then gained by 1.6% to $200.9 million in 2024, then increased by 10.42% to $221.9 million in 2025, then advanced by 0.47% to $222.9 million in 2026.
  • Business Quant data shows CERS's Liabilities and Shareholders Equity at $222.9 million in Q1 2026, $221.9 million in Q4 2025, and $215.2 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Abbott Laboratories 183.47 Bn 176.17 Bn 6.27 Bn 110.43 Bn
2 Stryker 128.89 Bn 126.01 Bn 3.81 Bn 46.29 Bn
3 Medtronic 108.71 Bn 99.49 Bn 6.41 Bn 93.03 Bn
4 Boston Scientific 68.50 Bn 67.05 Bn 3.61 Bn 44.35 Bn
5 Edwards Lifesciences 48.59 Bn 44.92 Bn 1.29 Bn 13.32 Bn
6 Dexcom 28.40 Bn 27.29 Bn 750.30 Mn 6.63 Bn
7 GE HealthCare Technologies 28.34 Bn 26.06 Bn 1.98 Bn 37.13 Bn
8 Smith & Nephew 26.93 Bn 26.35 Bn - 10.46 Bn
9 Koninklijke Philips 25.50 Bn 22.37 Bn 2.07 Bn 31.92 Bn
10 Cerus 602.81 Mn 522.39 Mn 27.89 Mn 222.91 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 222.91 Mn
Dec 31, 2025 221.86 Mn
Sep 30, 2025 215.19 Mn
Jun 30, 2025 213.07 Mn
Mar 31, 2025 206.78 Mn
Dec 31, 2024 200.92 Mn
Sep 30, 2024 189.54 Mn
Jun 30, 2024 185.50 Mn
Mar 31, 2024 189.14 Mn
Dec 31, 2023 197.75 Mn
Sep 30, 2023 205.84 Mn
Jun 30, 2023 198.86 Mn
Mar 31, 2023 209.34 Mn
Dec 31, 2022 218.09 Mn
Sep 30, 2022 215.40 Mn
Jun 30, 2022 216.46 Mn
Mar 31, 2022 221.91 Mn
Dec 31, 2021 237.50 Mn
Sep 30, 2021 218.95 Mn
Jun 30, 2021 223.22 Mn